Group 1 - The core point of the article is that Haoli Technology (002729.SZ) plans to reduce the registered capital of its wholly-owned subsidiary, Hangzhou Haolirunhui Private Fund Management Co., Ltd. from 30 million yuan to 18 million yuan to optimize resource allocation and focus on core business development [1] Group 2 - The registered capital of Haolirunhui is currently 30 million yuan [1] - The reduction in registered capital aims to improve the overall efficiency of the company's fund utilization [1] - After the capital reduction, the company will still hold 100% equity in Haolirunhui [1]

Group 1 - The core point of the article is that Haoli Technology (002729.SZ) plans to reduce the registered capital of its wholly-owned subsidiary, Hangzhou Haoli Profit Fund Management Co., Ltd. (referred to as "Haoli Profit"), from 30 million yuan to 18 million yuan to optimize resource allocation and focus on core business development [1] - The decision to reduce the registered capital is based on the current business development situation and future development plans of Haoli Profit [1] - After the capital reduction is completed, the company will still hold 100% equity of Haoli Profit [1]

Group 1 - The company, Shandong Huate Dain Health Co., Ltd., has completed the bankruptcy liquidation and deregistration process for its wholly-owned subsidiary, Shandong Huate Information Technology Co., Ltd. [1][2] - The bankruptcy application was filed by Huate Information on October 20, 2023, and the court accepted the application, appointing a manager for the liquidation process [2][4] - The court declared Huate Information bankrupt on December 11, 2024, and the bankruptcy proceedings were concluded on August 13, 2025 [3][4] Group 2 - The deregistration of Huate Information will not affect the company's normal production and profitability, and it aligns with the company's strategy to focus on children's health pharmaceuticals [4] - The company has made necessary accounting adjustments related to long-term equity investments and receivables associated with Huate Information [4]

Core Viewpoint - The company has decided to terminate the public listing for the sale of its subsidiary, LeKang Pharmaceutical, due to a lack of qualified buyers after one year and will instead transfer the ownership to LinYi JunKang for 62.5 million RMB [1] Group 1: Company Actions - The company held its 19th meeting of the 5th Board of Directors on November 18, 2024, where it approved the proposal to publicly list the sale of its subsidiary's equity [1] - The company’s subsidiary, Shandong LuoXin, will transfer 100% of its stake in LeKang Pharmaceutical to LinYi JunKang for a consideration of 62.5 million RMB [1] - Following the transfer, Shandong LuoXin will no longer hold any equity in LeKang Pharmaceutical, which will be excluded from the company’s consolidated financial statements [1] Group 2: Financial Implications - Prior to the transfer, Shandong LuoXin provided a loan of 2.8 million RMB to LeKang Pharmaceutical, which remains outstanding with a total amount of 2.8005 million RMB including interest [1] - The outstanding loan amount is expected to be settled by October 26, 2026, as confirmed by all parties involved [1]

Core Viewpoint - Longbai Group (002601.SZ) is divesting its 98.50% stake in a financing leasing company to focus on its core business and optimize resource allocation [1] Group 1: Transaction Details - Longbai Group will transfer 65.17% of its stake, with a subscribed capital of 195.5 million yuan and a paid-in capital of 170 million yuan, for a price of 194,976,123.36 yuan [1] - The Hong Kong subsidiary will transfer 33.33% of its stake, with a subscribed capital of 100 million yuan, for a price of 114,691,837.27 yuan [1] - Shenzhen Furun Holdings Co., Ltd. will transfer its 1.50% stake, with a subscribed capital of 4.5 million yuan, for a price of 5,161,132.68 yuan [1] Group 2: Post-Transaction Implications - After the transaction, the Jiaozuo State-owned Capital Operation Group will hold 100% of the financing leasing company [1] - Longbai Group and its Hong Kong subsidiary will no longer hold any equity in the financing leasing company and will exclude it from their consolidated financial statements [1]

Core Viewpoint - Longbai Group (002601.SZ) is divesting its 98.50% stake in a financing leasing company to focus on its core business and optimize resource allocation [1] Group 1: Transaction Details - Longbai Group will transfer 65.17% of its stake, corresponding to a subscribed capital of 195.5 million yuan and a paid-in capital of 170 million yuan, for a price of 194,976,123.36 yuan [1] - The Hong Kong subsidiary will transfer 33.33% of its stake, with a subscribed capital of 100 million yuan, fully paid, for a price of 114,691,837.27 yuan [1] - Shenzhen Furun Holdings Co., Ltd. will transfer its 1.50% stake, with a subscribed capital of 4.5 million yuan, fully paid, for a price of 5,161,132.68 yuan [1] Group 2: Post-Transaction Implications - After the transaction, the Jiaozuo State-owned Capital Operation Group will hold 100% of the financing leasing company, and Longbai Group and its Hong Kong subsidiary will no longer hold any equity in the financing leasing company [1] - The financing leasing company will be excluded from Longbai Group's consolidated financial statements following the completion of the transaction [1]

Core Viewpoint - The company, Aerospace Science and Technology Corporation, has decided to transfer 2.0126% of its stake in Aerospace Science and Technology Finance Co., Ltd. to China Aerospace Science and Technology Group Co., Ltd. for a price of approximately 179.43 million yuan, aiming to focus on its core business and optimize resource allocation [2][3]. Group 1: Board Meeting Decisions - The board meeting was held on December 26, 2025, with all 9 directors participating and the resolutions passed being valid and in compliance with relevant laws [1][3]. - The proposal to transfer the stake in the finance company and waive the right of first refusal was approved unanimously [4][6]. - The independent directors supported the transaction, stating it would optimize resource allocation and not significantly impact the company's management or financial results [3][6]. Group 2: Upcoming Shareholder Meeting - A proposal to convene the first extraordinary general meeting of shareholders in 2026 was also approved [5][6]. - The meeting is scheduled for January 12, 2026, with both on-site and online voting options available for shareholders [12][13]. - The agenda will include the approval of the stake transfer proposal, with related shareholders required to abstain from voting [14][15].

Core Viewpoint - The company, Aucma, is planning to publicly transfer 55% of its stake in Qingdao Aucma Information Industry Park Co., Ltd. through the Qingdao Property Rights Exchange, with a minimum transfer price set at 92.4591 million yuan [1][2]. Group 1: Share Transfer - Aucma will no longer hold any shares in the Information Industry Park Company after the transfer is completed [1][2]. - The Information Industry Park Company was established in May 2014 and has developed the Laoshan Smart Industrial Park, which was completed in 2019 [1]. - The company’s main income source will be rental income from properties it holds after the split in 2024 [1]. Group 2: Internal Restructuring - Aucma plans to transfer 100% of its stake in Qingdao Aucma Smart Cold Chain Co., Ltd. to its wholly-owned subsidiary, Qingdao Aucma Commercial Appliances Co., Ltd., without any payment [2][3]. - This transfer aims to enhance operational efficiency and optimize internal resource allocation [2][3]. - The Smart Cold Chain Company reported total assets of 1.537 billion yuan and net profit of 47.7227 million yuan for the year ending December 31, 2024 [3].

Core Viewpoint - The company is planning to sell a 49% stake in Ulanqab Dasheng Graphite New Materials Co., Ltd. for a base price of 206 million yuan, following the completion of auditing and evaluation work [1] Group 1: Company Actions - The board of directors approved the proposal to sell the stake on October 27, 2025 [1] - The sale aims to respond to the company's strategy of divesting low-efficiency assets and accelerating liquidity recovery [1] - The transaction is expected to optimize resource allocation and strengthen the company's focus on its core business [1] Group 2: Business Overview - Dasheng Graphite specializes in the deep processing of natural graphite, with core products including high-purity graphite, expandable graphite, conductive agents, lithium-ion battery anode materials, and graphitization processing services [1] - The downstream applications of Dasheng Graphite's products cover metallurgy, chemicals, electronics, new energy batteries, and thermal sealing [1]

Core Viewpoint - The company is planning to sell a 49% stake in Ulanqab Dasheng Graphite New Materials Co., Ltd. for a base price of 206 million yuan, following the completion of auditing and evaluation work [1] Group 1: Company Actions - The board of directors approved the proposal to sell the stake on October 27, 2025 [1] - The sale aims to respond to the company's strategy of divesting low-efficiency assets and accelerating liquidity recovery [1] - The transaction is expected to optimize resource allocation and strengthen the company's focus on its core business [1] Group 2: Business Overview - Dasheng Graphite specializes in the deep processing of natural graphite, with core products including high-purity graphite, expandable graphite, conductive agents, lithium-ion battery anode materials, and graphitization processing services [1] - The downstream applications of Dasheng Graphite's products cover metallurgy, chemicals, electronics, new energy batteries, and sealing heat dissipation [1]